GLP-1 TV
150: Why Tirzepatide Works Better Than GLP-1 Alone
Today’s cheapest GLP-1$39/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.Our summary
In this lecture from his Metabolic Classroom series, the channel describes tirzepatide as a single synthetic peptide that activates both the GIP and GLP-1 receptors. He says it is given as a weekly injection, with doses in the major trials ranging from 5 mg up to about 15 mg weekly. According to the video, head-to-head comparisons show more weight loss and better glucose control than semaglutide, a GLP-1-only drug.
Published by Ben Bikman on YouTube
As published by the channel. Not medical advice, and not an endorsement.
What else the video covers
A large part of the talk argues against the idea that tirzepatide works by raising insulin. The speaker cites a 28-week trial in adults with type 2 diabetes in which fasting insulin fell and insulin sensitivity roughly doubled. He also cites the SURPASS 5 trial, where people already on insulin glargine needed less injected insulin with tirzepatide than the placebo group, and up to 90% reached their glucose target compared with about a third on placebo. He says weight loss comes mainly from reduced appetite, weaker food reward signals in the brain and slower gastric emptying, which lower carbohydrate and calorie intake.
On the GIP paradox, the speaker says GIP promotes fat storage only when insulin is elevated, and that tirzepatide lowers insulin and cravings for sugary and starchy foods. He also says GIP may ease the nausea that limits GLP-1 dosing, though nausea rates were similar to semaglutide in head-to-head trials. He closes by saying he sees these drugs as a temporary tool for regaining control of carbohydrate cravings and changing eating habits.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 2:00 The speaker explains that tirzepatide mimics two gut hormones, GIP and GLP-1, in one molecule, and that it is dosed weekly from 5 mg up to about 15 mg.
- 8:15 He cites a 28-week trial in adults with type 2 diabetes in which fasting insulin went down and insulin sensitivity roughly doubled.
- 10:43 He describes the SURPASS 5 trial, where adding tirzepatide to insulin glargine improved glucose control with less injected insulin than placebo.
- 13:31 He says weight loss is driven by appetite suppression in the brain and slower gastric emptying, which reduce carbohydrate and calorie intake.
- 17:00 He explains that GIP promotes fat storage only when insulin is high, a condition he says tirzepatide undoes by lowering insulin and carb cravings.
- 27:00 He says GIP may reduce the nausea that limits GLP-1 dosing, but nausea rates were similar between tirzepatide and semaglutide in head-to-head trials.
Key moments
Tap one to play from there.
- 0:00 <Untitled Chapter 1>
- 1:03 Introduction: Tirzepatide and the Incretin System
- 2:06 GLP-1 and GIP: The Two Incretin Hormones
- 4:10 GLP-1’s Effects on Appetite, Glucagon, and Gastric Emptying
- 5:13 What Tirzepatide Is
- 7:19 Why Tirzepatide Is Not Simply “Raising Insulin”
- 8:20 Tirzepatide Improves Insulin Sensitivity
- 10:54 The Insulin-Sparing Effect
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- semaglutide and tirzepatide
- Side effects mentioned
- nausea, vomiting and low appetite
Questions this video answers
Does tirzepatide work by raising insulin?
The speaker says no. He cites trials in which fasting insulin fell, insulin sensitivity improved, and people on insulin needed less of it. He says incretin effects on insulin depend on high glucose, which he says does not occur in normal meals on the drug.
Why does tirzepatide cause more weight loss than semaglutide?
According to the video, tirzepatide activates both GIP and GLP-1 receptors. The speaker says both reduce appetite, and GIP may ease nausea so higher GLP-1 dosing is tolerated. He notes head-to-head trials show more weight loss at similar nausea rates.
How often is tirzepatide taken and at what dose?
The speaker says tirzepatide has a half-life of about 5 days, so it is given as a single weekly injection. He says doses in the major trials range from 5 mg up to about 15 mg weekly.
Does tirzepatide cause muscle loss according to the channel?
He says some of the apparent loss of fat-free mass on DEXA scans appears to come from the liver shrinking as it loses fat, not from muscle. He explains that DEXA counts liver mass as fat-free mass.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
Semaglutide vs Tirzepatide! WHICH ONE? My experience on both GLP-1 medications!!The channel, who says she is not a medical professional, compares semaglutide and tirzepatide based on her own use of both.- Already on a GLP-1? What your next month costs at every programToday’s lowest is $39/mo. Every program ranked by price alone. Compounded drugs are not FDA-approved.
Tirzepatide vs Semaglutide: I've Prescribed Both — Here's the Honest TruthThe speaker, an obesity and telemedicine physician, compares tirzepatide and semaglutide.
Mounjaro (tirzepatide)... How does it work?In this talk, the speaker, an endocrinologist in Austin, Texas, explains Mounjaro (tirzepatide) from Eli Lilly.
Paggamit ng Tirzepatide, delikado nga ba?In this segment, a doctor is interviewed about tirzepatide and whether using it is risky.
Tirzepatide: You Don't Know What It's Actually Doing to Your Body | A Doctor ExplainsIn this video, the speaker, a physician who works in medical weight management and says he has lost around 70 pounds himself, argues that tirzepatide does more than reduce appetite.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- GLP-1 vs GLP-2 vs GLP-3: what the names mean, and which ones you can actually buy
GLP-1 drugs such as semaglutide act on one receptor. "GLP-2" is used online for tirzepatide (Zepbound, Mounjaro), which acts on two, GIP and GLP-1, and "GLP-3" for retatrutide, which adds the glucagon receptor. Neither nickname is the real name: GLP-2 is a separate gut hormone whose drug, Gattex, treats short bowel syndrome. Retatrutide produced 28.3% mean weight loss at 80 weeks in its phase 3 trial but is not FDA-approved; Lilly plans to file in Q1 2027. Tirzepatide is the strongest option you can buy today.
- What is GLP-1? The hormone, how the drugs work, and every GLP-1 medication on the market
GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after you eat. It tells the pancreas to release insulin when blood sugar is high, holds back glucagon, slows how fast the stomach empties, and acts on the parts of the brain that regulate appetite. GLP-1 drugs copy that hormone but last far longer: a week for the injections, a day for the pills. Seven brands are on the US market, from Ozempic and Mounjaro for type 2 diabetes to Wegovy, Zepbound and Foundayo for weight loss.
- What is Zepbound? Tirzepatide explained: what it treats, how it works, and what it costs
Zepbound is Eli Lilly's brand of tirzepatide, a once-weekly injection that acts on two hormone receptors, GIP and GLP-1. The FDA label approves it, with diet and exercise, for weight reduction in adults with obesity or overweight plus a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity. In the SURMOUNT-5 trial it produced 20.2% average weight loss at 72 weeks against 13.7% for semaglutide. Lilly sells it self-pay from $299 a month.
Next steps
Compounded semaglutide prices
Find more like it
Side effectsDose changeWeigh-in and resultsFood, protein and eatingFood noise and cravingsHow it worksThe trialsNauseaVomitingLow appetite
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.




















